Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Westfield Capital Management Co. LP

Westfield Capital Management Co. LP boosted its holdings in Axon Enterprise, Inc. (NASDAQ:AXONFree Report) by 5.1% in the 4th quarter, HoldingsChannel.com reports. The firm owned 731,721 shares of the biotechnology company’s stock after buying an additional 35,528 shares during the quarter. Axon Enterprise comprises approximately 1.1% of Westfield Capital Management Co. LP’s investment portfolio, making the stock its 14th biggest holding. Westfield Capital Management Co. LP’s holdings in Axon Enterprise were worth $189,025,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. increased its stake in shares of Axon Enterprise by 6.1% during the 4th quarter. Nomura Asset Management Co. Ltd. now owns 18,568 shares of the biotechnology company’s stock valued at $4,797,000 after acquiring an additional 1,065 shares during the last quarter. Advisory Services Network LLC acquired a new position in Axon Enterprise during the fourth quarter worth approximately $180,000. Cambridge Investment Research Advisors Inc. raised its stake in Axon Enterprise by 6.9% during the fourth quarter. Cambridge Investment Research Advisors Inc. now owns 8,251 shares of the biotechnology company’s stock worth $2,131,000 after purchasing an additional 535 shares during the period. Annis Gardner Whiting Capital Advisors LLC boosted its holdings in shares of Axon Enterprise by 13.2% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 2,405 shares of the biotechnology company’s stock valued at $621,000 after purchasing an additional 280 shares during the last quarter. Finally, Assetmark Inc. grew its stake in shares of Axon Enterprise by 8.0% during the 4th quarter. Assetmark Inc. now owns 4,438 shares of the biotechnology company’s stock valued at $1,146,000 after buying an additional 329 shares during the period. 79.08% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

AXON has been the topic of several research reports. Craig Hallum lifted their target price on Axon Enterprise from $325.00 to $370.00 and gave the company a “buy” rating in a report on Tuesday, May 7th. Argus assumed coverage on shares of Axon Enterprise in a research report on Wednesday, March 13th. They set a “buy” rating and a $380.00 target price for the company. The Goldman Sachs Group lifted their price target on shares of Axon Enterprise from $297.00 to $339.00 and gave the company a “buy” rating in a research report on Wednesday, February 28th. Needham & Company LLC reissued a “buy” rating and issued a $400.00 price objective on shares of Axon Enterprise in a research report on Tuesday, May 7th. Finally, Robert W. Baird raised their target price on shares of Axon Enterprise from $260.00 to $300.00 and gave the company an “outperform” rating in a research note on Thursday, February 22nd. Two equities research analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $335.27.

Read Our Latest Analysis on AXON

Insider Transactions at Axon Enterprise

In other news, President Joshua Isner sold 44,000 shares of the company’s stock in a transaction dated Thursday, May 9th. The shares were sold at an average price of $309.96, for a total value of $13,638,240.00. Following the sale, the president now owns 275,843 shares in the company, valued at approximately $85,500,296.28. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Axon Enterprise news, insider Jeffrey C. Kunins sold 43,668 shares of the business’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $309.94, for a total transaction of $13,534,459.92. Following the completion of the sale, the insider now owns 189,719 shares in the company, valued at $58,801,506.86. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 44,000 shares of the firm’s stock in a transaction dated Thursday, May 9th. The stock was sold at an average price of $309.96, for a total transaction of $13,638,240.00. Following the completion of the transaction, the president now owns 275,843 shares in the company, valued at $85,500,296.28. The disclosure for this sale can be found here. Over the last quarter, insiders sold 87,976 shares of company stock valued at $27,268,201. 6.10% of the stock is currently owned by corporate insiders.

Axon Enterprise Stock Up 2.0 %

Shares of Axon Enterprise stock traded up $5.64 during trading hours on Friday, hitting $285.63. 410,847 shares of the company’s stock traded hands, compared to its average volume of 498,095. Axon Enterprise, Inc. has a twelve month low of $175.37 and a twelve month high of $329.87. The company has a market cap of $21.56 billion, a PE ratio of 83.52 and a beta of 0.91. The company has a quick ratio of 2.55, a current ratio of 2.91 and a debt-to-equity ratio of 0.37. The stock has a 50 day simple moving average of $306.23 and a 200-day simple moving average of $274.04.

Axon Enterprise (NASDAQ:AXONGet Free Report) last issued its quarterly earnings data on Friday, May 10th. The biotechnology company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.95 by $0.20. Axon Enterprise had a return on equity of 11.71% and a net margin of 15.60%. The firm had revenue of $460.74 million during the quarter, compared to analyst estimates of $441.57 million. During the same quarter last year, the firm earned $0.51 EPS. Axon Enterprise’s quarterly revenue was up 34.3% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc. will post 2.35 earnings per share for the current fiscal year.

Axon Enterprise Profile

(Free Report)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

See Also

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXONFree Report).

Institutional Ownership by Quarter for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.